| Display title | Medicine:Drug-induced autoimmune hemolytic anemia |
| Default sort key | Drug-induced autoimmune hemolytic anemia |
| Page length (in bytes) | 17,233 |
| Namespace ID | 3048 |
| Namespace | Medicine |
| Page ID | 540816 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>AnLinks |
| Date of page creation | 03:33, 5 February 2024 |
| Latest editor | imported>AnLinks |
| Date of latest edit | 03:33, 5 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Drug-induced autoimmune hemolytic anemia also known as Drug-induced immune hemolytic anemia (DIIHA) is a rare cause of hemolytic anemia. It is difficult to differentiate from other forms of anemia which can lead to delays in diagnosis and treatment. Many different types of antibiotics can cause DIIHA... |
